Capital Performance Advisors’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-41
Closed -$1.12K 1736
2024
Q3
$1.12K Buy
+41
New +$1.12K ﹤0.01% 1850